Amplitude Surgical SAS (AMPLI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) has a cash flow conversion efficiency ratio of 0.029x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.77 Million ≈ $3.24 Million USD) by net assets (€94.70 Million ≈ $110.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Amplitude Surgical SAS for the company's overall valuation and market capitalisation.
Amplitude Surgical SAS - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Amplitude Surgical SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Amplitude Surgical SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amplitude Surgical SAS ranked by their cash flow conversion efficiency. Explore Amplitude Surgical SAS (AMPLI) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Henan Provincial Communications Planning & Design Institute Co Ltd Class A
SHE:300732
|
0.025x |
|
908 Devices Inc
NASDAQ:MASS
|
0.008x |
|
Shenzhen Jianyi Decoration Group Co Ltd
SHE:002789
|
0.236x |
|
Rongyu Group Co Ltd
SHE:002622
|
0.057x |
|
Sarana Meditama Metropolitan
JK:SAME
|
0.011x |
|
Agencia Comercial Spirits Ltd Class A Ordinary Shares
NASDAQ:AGCC
|
N/A |
|
Lineage Cell Therapeutics Inc
NYSE MKT:LCTX
|
-0.174x |
|
Antibiotice Ia
RO:ATB
|
0.020x |
Annual Cash Flow Conversion Efficiency for Amplitude Surgical SAS (2011–2024)
The table below shows the annual cash flow conversion efficiency of Amplitude Surgical SAS from 2011 to 2024. View current stock price of Amplitude Surgical SAS for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | €95.82 Million ≈ $112.02 Million |
€4.04 Million ≈ $4.73 Million |
0.042x | -50.07% |
| 2023-06-30 | €95.81 Million ≈ $112.02 Million |
€8.10 Million ≈ $9.47 Million |
0.084x | -44.36% |
| 2022-06-30 | €52.57 Million ≈ $61.46 Million |
€7.98 Million ≈ $9.33 Million |
0.152x | +268.42% |
| 2021-06-30 | €56.87 Million ≈ $66.48 Million |
€2.34 Million ≈ $2.74 Million |
0.041x | -76.40% |
| 2020-06-30 | €70.91 Million ≈ $82.90 Million |
€12.38 Million ≈ $14.48 Million |
0.175x | +81.15% |
| 2019-06-30 | €85.50 Million ≈ $99.95 Million |
€8.24 Million ≈ $9.64 Million |
0.096x | +1.63% |
| 2018-06-30 | €94.68 Million ≈ $110.69 Million |
€8.98 Million ≈ $10.50 Million |
0.095x | +265.03% |
| 2017-06-30 | €103.14 Million ≈ $120.58 Million |
€2.68 Million ≈ $3.13 Million |
0.026x | +54.47% |
| 2016-06-30 | €118.12 Million ≈ $138.09 Million |
€1.99 Million ≈ $2.32 Million |
0.017x | +112.09% |
| 2015-06-30 | €118.76 Million ≈ $138.84 Million |
€-16.53 Million ≈ $-19.33 Million |
-0.139x | -59.01% |
| 2014-06-30 | €22.31 Million ≈ $26.08 Million |
€-1.95 Million ≈ $-2.28 Million |
-0.088x | -1008.15% |
| 2013-06-30 | €20.44 Million ≈ $23.89 Million |
€197.00K ≈ $230.31K |
0.010x | +106.61% |
| 2012-06-30 | €22.40 Million ≈ $26.18 Million |
€-3.26 Million ≈ $-3.82 Million |
-0.146x | -8.89% |
| 2011-06-30 | €25.40 Million ≈ $29.69 Million |
€-3.40 Million ≈ $-3.97 Million |
-0.134x | -- |
About Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more